Gyre Therapeutics, Inc.GYRENASDAQ
Loading
Revenue ScalingExpanding
Percentile Rank100
3Y CAGR+4.5%
5Y CAGR+41.0%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
+4.5%/yr
vs +1042.7%/yr prior
5Y CAGR
+41.0%/yr
Recent deceleration
Acceleration
-1038.2pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
5.6x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$116.59M+10.2%
2024$105.76M-6.8%
2023$113.45M+10.9%
2022$102.29M+1294.0%
2021$7.34M-65.0%
2020$20.95M-
2019$0.00-100.0%
2018$6000.00-99.4%
2017$1.02M+155.1%
2016$399000.00-